BioScrip

BioScrip® is a leading provider in comprehensive, cost-effective pharmaceutical and home care solutions. Our goal is to partner with patients, physicians, healthcare payors, government agencies and pharmaceutical manufacturers to provide access to infusible medications and management solutions that optimize outcomes for chronic and other complex healthcare conditions. At BioScrip, our patients receive personalized, safe, effective and convenient infusion therapies to help improve quality of life. Our team of professionals assist each patient in every step of their office or home infusion experience.
Company Growth (employees)
Type
Public
HQ
Denver, US
Size (employees)
2,039 (est)
BioScrip is headquartered in Denver, US

Key People at BioScrip

Richard M. Smith

Richard M. Smith

President & CEO

BioScrip Office Locations

BioScrip has offices in Denver, Eden Prairie and Elmsford
Denver, US (HQ)
950 1600 Broadway
Elmsford, US
100 Clearbrook Road
Eden Prairie, US
10050 Crosstown Circle

BioScrip Data and Metrics

BioScrip Financial Metrics

BioScrip's revenue was reported to be $935.6 m in FY, 2016 which is a 5% decrease from the previous period.
USD

Revenue (FY, 2016)

935.6 m

Revenue growth (FY, 2015 - FY, 2016), %

(5%)

Gross profit (FY, 2016)

265.6 m

Gross profit margin (FY, 2016), %

28%

Net income (FY, 2016)

(41.5 m)

Market capitalization (21-Sep-2017)

284.8 m

Cash (31-Mar-2017)

16 m
BioScrip's current market capitalization is $284.8 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

842.2 m984.1 m982.2 m935.6 m

Revenue growth, %

17%(0%)(5%)

Cost of goods sold

721.3 m670 m

Gross profit

260.9 m265.6 m
USDFY, 2015FY, 2016

Cash

15.6 m9.6 m

Inventories

20 m36.2 m

Current Assets

187 m176.1 m

PP&E

31.9 m32.5 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

1.5 m23.2 m1.2 m29.4 m8.1 m51.4 m2.8 m16 m

Inventories

34.5 m33.8 m41.9 m42.4 m26.9 m29.1 m32.4 m33.4 m30.5 m

Current Assets

238.8 m215.6 m212.4 m185.4 m199.4 m158.8 m199 m159.4 m176 m

PP&E

39.9 m40 m35.9 m34.9 m34.1 m30.5 m30.8 m33.7 m30.4 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(299.7 m)(41.5 m)

Depreciation and Amortization

22.7 m21.6 m

Inventories

(5.8 m)10 m

Accounts Payable

(24.1 m)(20.5 m)
Show all financial metrics

BioScrip Market Value History

Traffic Overview of BioScrip

BioScrip Online and Social Media Presence

BioScrip News and Updates

BRIEF-BioScrip prices 40 mln shares offering at $2.00 per share

* Says offering of 40.0 million common shares priced at $2.00 per share

BioScrip Company Life and Culture

You may also be interested in